Liminatus Pharma, Inc. Class A Common Stock(LIMN)

Biotechnology · Cerritos, CA

$3.87-0.12 (-3.01%)

Delayed quote: Oct 6, 2026, 10:41 AM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T14:52:54.199Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:52:54.199Z.

Quote observation: 2026-10-06T14:41:29.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -3,972,747
Quote market capitalization: 5,198,211

FMP input reference: d2baa5019f568993ecceb1943c30cf17443c8d153a00c2cc4d930c3e59df60e4

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LIMN Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

LIMN Competitors' Operating Cash Flow Yield

LIMN

Liminatus Pharma, Inc. Class A Common Stock

Current

Market Cap

$5.20M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LNAI

Lunai Bioworks Inc.

vs LIMN

Market Cap

$5.17M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GELS

Gelteq Limited Ordinary Shares

vs LIMN

Market Cap

$5.17M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBS

Intelligent Bio Solutions Inc.

vs LIMN

Market Cap

$5.27M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALZN

Alzamend Neuro Inc

vs LIMN

Market Cap

$5.36M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMGL

Basel Medical Group Ltd Ordinary Shares

vs LIMN

Market Cap

$5.01M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMNN

Imunon, Inc.

vs LIMN

Market Cap

$4.99M

Operating Cash Flow Yield

N/A

TTM Avg

7.23%

3Y Avg

6.60%

5Y Avg

6.60%

ACXP

Acurx Pharmaceuticals, Inc.

vs LIMN

Market Cap

$5.54M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGMS

Bio Green Med Solution, Inc.

vs LIMN

Market Cap

$4.83M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LEXX

Lexaria Bioscience Corp.

vs LIMN

Market Cap

$4.79M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Liminatus Pharma, Inc. Class A Common Stock (LIMN)	$5.20M	N/A	N/A	N/A	N/A
Lunai Bioworks Inc. (LNAI)vs ›	$5.17M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.17M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.27M	N/A	N/A	N/A	N/A
Alzamend Neuro Inc (ALZN)vs ›	$5.36M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.01M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$4.99M	N/A	7.23%	6.60%	6.60%
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.54M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.83M	N/A	N/A	N/A	N/A
Lexaria Bioscience Corp. (LEXX)vs ›	$4.79M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

LIMN Operating Cash Flow Yield Metrics

LIMN Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics